Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New inhaled drug could help lung disease patients breathe easier and walk farther

NCT ID NCT07285655

Disease control Sponsor: Liquidia Technologies, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 03, 2026 · Updated 4 times

Summary

This study tests an inhaled medicine called L606 for people with high blood pressure in the lungs due to lung disease. About 344 adults will be randomly assigned to receive L606 or a placebo. The main goal is to see if L606 helps them walk farther in six minutes and delays worsening of their condition. Safety will be closely monitored.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 344 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant is between 18 years to 80 years old. * Has a confirmed diagnosis of ILD based on High Resolution Computed Tomography (HRCT) chest imaging. * Evidence of PH as demonstrated from Right Heart Catheterization (RHC) with the following hemodynamic parameters: * Pulmonary vascular resistance (PVR) ≥ 320 dynes.sec/cm5 (i.e. 4 Woods Units (WU)), and * Mean Pulmonary Artery Pressure (mPAP) of ≥ 25 mmHg, and * \- Pulmonary capillary wedge pressure (PCWP) or Left-Ventricular End Diastolic Pressure (LVEDP) of ≤ 15 mmHg. * FEV1/FVC (ratio) \> 0.70. * 6-minute walk distance ≥ 150 meters Exclusion Criteria: * PH in the updated WHO Classification Groups 1, 2, 4, or 5. * Has evidence of clinically significant left-sided heart disease as defined by echocardiography. * Participants with history of persistent/permanent or uncontrolled atrial fibrillation. * Participants with severe obstructive sleep apnea. * Has experienced exacerbation of underlying lung disease or active respiratory infection requiring antibiotics. * Initiation of pulmonary rehabilitation. Note: Other protocol defined inclusion/exclusion criteria may apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pulmonary hypertension due to lung disease (disorder) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

interstitial lung disease pulmonary hypertension pulmonary hypertension owing to lung disease and/or hypoxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pulmonary hypertension due to lung disease (disorder)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    36 sites in 11 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Arizona Pulmonary Specialists, Ltd.

    RECRUITING

    Scottsdale, Arizona, 85258, United States

  • Assistance Publique Hopitaux De Paris

    RECRUITING

    Le Kremlin-Bicêtre, 94270, France

  • Azienda Ospedaliero-Universitaria Policlinico Umberto I

    RECRUITING

    Rome, 00161, Italy

  • David Geffen School of Medicine at UCLA

    RECRUITING

    Los Angeles, California, 90095-1690, United States

  • Dignity Health - St. Joseph's Hospital and Medical Center

    RECRUITING

    Phoenix, Arizona, 85013, United States

  • Hospital Clinic De Barcelona

    RECRUITING

    Barcelona, 08036, Spain

  • Hospital Del Mar

    RECRUITING

    Barcelona, 08003, Spain

  • Hospital Universitario Marques De Valdecilla

    RECRUITING

    Santander, 39008, Spain

  • IRCCS Ospedale Policlinico San Martino

    RECRUITING

    Genoa, 16132, Italy

  • Krankenhaus Neuwittelsbach

    RECRUITING

    Munich, 80639, Germany

  • LMU Klinikum Muenchen AöR

    RECRUITING

    Munich, 81377, Germany

  • Medizinische Hochschule Hannover

    RECRUITING

    Hanover, 30625, Germany

  • NYU Langone Health

    RECRUITING

    New York, New York, 10016, United States

  • National Jewish Hospital

    RECRUITING

    Denver, Colorado, 80206, United States

  • Northwestern University

    RECRUITING

    Chicago, Illinois, 60611, United States

  • Ordensklinikum Linz GmbH

    RECRUITING

    Linz, 4020, Austria

  • Pauls Stradinš Clinical University Hospital

    RECRUITING

    Riga, LV-1002, Latvia

  • Royal Bromptom Hospital

    RECRUITING

    London, SW3 6NP, United Kingdom

  • Royal Free London NHS Foundation Trust Hospital - Royal Free Hospital

    RECRUITING

    London, NW3 2QG, United Kingdom

  • Royal Hobart Hospital

    RECRUITING

    Hobart, Tasmania, 7000, Australia

  • Royal United Hospitals Bath NHS Foundation Trust

    RECRUITING

    Bath, United Kingdom

  • Sheffield Teaching Hospital NHS Foundation Trust - Royal Hallamshire Hospital

    RECRUITING

    Sheffield, S10 2JF, United Kingdom

  • St. Vincent Cardiovascular Research Institute

    RECRUITING

    Indianapolis, Indiana, 46260, United States

  • Summit Health

    RECRUITING

    Bend, Oregon, 97701, United States

  • Tampa General Hospital

    RECRUITING

    Tampa, Florida, 33606, United States

  • Unidade Local De Saude De Almada-Seixal E.P.E.

    RECRUITING

    Almada, 2805-267, Portugal

  • Unidade Local De Saude De Santo Antonio E.P.E.

    RECRUITING

    Porto, 4050-011, Portugal

  • Universitaetsklinikum Koeln AöR

    RECRUITING

    Cologne, 50937, Germany

  • Universitaetsmedizin Greifswald KöR

    RECRUITING

    Greifswald, 17489, Germany

  • Universitair Ziekenhuis Gent

    RECRUITING

    Ghent, 9000, Belgium

  • University Hospitals Plymouth NHS Trust - Derriford Hospital

    RECRUITING

    Plymouth, PL6 8DH, United Kingdom

  • University Medical Center Hamburg-Eppendorf

    RECRUITING

    Hamburg, 20246, Germany

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

  • University of Colorado Hospital

    RECRUITING

    Aurora, Colorado, 80045, United States

  • University of Rochester Medical Center

    RECRUITING

    Rochester, New York, 14642, United States

  • Universitätsklinikum Giessen und Marburg - Standort Giessen

    RECRUITING

    Giessen, 35392, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.